The alliance will provide Allarae with access to an established global distribution channel for immediate sale of its products and services in about 30 countries outside the US, while making Lobeck products available to Allarae for exclusive distribution in the US. Both companies will centralize manufacturing and warehousing at Lobeck central manufacturing facilities in Frick, Switzerland.
Under the main provisions of the agreement, Allarae will make available a comprehensive software system for test result tracking and monitoring under the ‘MediSmart of Switzerland’ brand. The software will integrate all the test kits and medical devices into a central data vault and tracking network, thereby creating a unique, first-to-market international offering.
In order to manage the venture, a jointly owned subsidiary is being established in Nevada along with a sales office in Dallas, Texas. The Nevada operation will be responsible for distribution in North America as well as for management of the FDA approval process.
Together the two companies will launch several innovative new products and services in 2008 and in the future. A few include tests for very early cancer detection and monitoring, a system for strep throat detection, prostate PSA screening and flu virus screening.